Panel Detail

Sunday, September 9, 2012
10:40 AM - 11:30 AM

Leveraging Medical Philanthropy


Leon Black, Founding Partner, Apollo Management; Co-founder, Melanoma Research Alliance
Gordon Gund, Co-founder, Foundation Fighting Blindness
David Koch, Executive Vice President, Koch Industries; Koch Institute for Integrative Cancer Research at MIT
Melissa Stevens, Deputy Executive Director, FasterCures


Michael Milken, Chairman, Milken Institute, and Founder, FasterCures
Philanthropic investment accounts for 3 percent of overall medical research spending, but plays an outsized role by fostering innovative R&D models that can accelerate the development of life-saving therapies. These investments can catalyze high-risk research too often abandoned by government and industry, stimulate fruitful collaborations among nontraditional allies, and refocus a research field on unmet patient needs. Hear from venture philanthropists who are using their passion capital and private sector savvy to redefine the medical research status quo and realize research progress for patients in their lifetime.

Panel Video

th leveraging

Click image above to play video